Key terms
About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest QGEN news
Yesterday
2:45am ET
Analysts Are Bullish on Top Healthcare Stocks: Qiagen (QGEN), Inari Medical (NARI)
May 01
9:51pm ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Medios AG (OtherMEDOF)
May 01
7:31am ET
Qiagen Exceeds Q1 Expectations, Affirms 2024 Outlook
May 01
7:31am ET
Qiagen Reports Q1 2024 Financial Results
Apr 30
9:55am ET
Berenberg Bank Sticks to Their Buy Rating for Qiagen (QGEN)
Apr 30
9:36am ET
Deutsche Bank Remains a Buy on Qiagen (QGEN)
Apr 30
9:32am ET
Analysts’ Top Healthcare Picks: Qiagen (QGEN), Eli Lilly & Co (LLY)
Apr 30
9:30am ET
Bank of America Securities Remains a Buy on Qiagen (QGEN)
Apr 30
7:32am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Qiagen (QGEN) and Zoetis (ZTS)
Apr 30
1:55am ET
Jefferies Keeps Their Hold Rating on Qiagen (QGEN)
Apr 30
1:35am ET
UBS Sticks to Its Hold Rating for Qiagen (QGEN)
Apr 29
4:17pm ET
Qiagen sees FY24 adjusted EPS $2.10, consensus $2.11
Apr 29
4:14pm ET
Qiagen reports Q1 adjusted EPS 46c, consensus 44c
Apr 17
10:35am ET
Bank of America Securities Reaffirms Their Buy Rating on Qiagen (QGEN)
Apr 17
4:10am ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Innate Pharma SA (OtherIPHYF) and Neumora Therapeutics, Inc. (NMRA)
Apr 16
7:05am ET
Deutsche Bank Remains a Buy on Qiagen (QGEN)
Mar 01
3:25am ET
UBS Sticks to Their Hold Rating for Qiagen (QGEN)
Feb 16
9:37am ET
UPS upgraded, Nike downgraded: Wall Street’s top analyst calls
Feb 16
7:52am ET
Qiagen upgraded to Overweight from Equal Weight at Morgan Stanley
Feb 16
3:05am ET
Berenberg Bank Reaffirms Their Buy Rating on Qiagen (QGEN)
Feb 15
9:25pm ET
Goldman Sachs Reaffirms Their Sell Rating on Qiagen (QGEN)
Feb 09
12:57am ET
Buy Recommendation for Qiagen: Anticipated Growth and Strategic Underpromise
Feb 08
8:35pm ET
Kepler Capital Keeps Their Hold Rating on Qiagen (QGEN)
Feb 08
6:38am ET
Qiagen price target lowered to $60 from $61.86 at Citi
Feb 08
5:18am ET
Maintaining Buy on Qiagen: Strong Q4 Performance and Positive Long-Term Outlook
Feb 07
9:40pm ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Ascendis Pharma (ASND)
Feb 07
8:41am ET
UBS Remains a Hold on Qiagen (QGEN)
Feb 07
8:41am ET
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Qiagen (QGEN) and Inspire Medical Systems (INSP)
Feb 07
8:40am ET
Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)
Feb 07
8:21am ET
Analysts’ Top Healthcare Picks: Amgen (AMGN), Qiagen (QGEN)
Feb 07
7:10am ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Inspire Medical Systems (INSP) and Gilead Sciences (GILD)
No recent press releases are available for QGEN
QGEN Financials
Key terms
Ad Feedback
QGEN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
QGEN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
